Hexo Corp Investor Dashboard

Company Overview:

HEXO Corp is an award-winning consumer packaged goods cannabis company that creates and distributes prize-winning products to serve the global cannabis market. Through its hub and spoke business strategy, HEXO Corp is partnering with Fortune 500 companies, bringing its brand value, cannabinoid isolation technology, licensed infrastructure and regulatory expertise to established companies, leveraging their distribution networks and capacity. As one of the largest licensed cannabis companies in Canada, HEXO Corp operates with 1.8 million sq. ft of facilities in Ontario and Quebec and a foothold in Greece to establish a Eurozone processing, production and distribution centre. The Company serves the Canadian adult-use and medical markets.

[stock_market_chart symbol=”HEXO.TO” range=”1y” settings='{“primaryChartType”:”smoothedLine”,”width”:”100%”,”height”:”350px”,”marginTop”:0,”marginBottom”:0,”marginLeft”:10,”marginRight”:10,”primaryPanelTitle”:”Price”,”secondaryPanelTitle”:”Volume”,”fontSize”:13,”color”:”#383838″,”primaryLineColor”:”#000″,”primaryLineColorAlpha”:0.15,”secondaryLineColor”:”#000″,”secondaryLineColorAlpha”:0.15,”backgroundColor”:”#fff”,”gridColor”:”#e0e0e0″,”gridAlpha”:0.8,”cursorColor”:”#ba0000″,”cursorAlpha”:0.8,”scrollbarBackgroundColor”:”#fff”,”scrollbarSelectedBackgroundColor”:”#000″,”scrollbarGraphFillColor”:”#000″,”scrollbarSelectedGraphFillColor”:”#000″,”primaryLineThickness”:0,”secondaryLineThickness”:0,”gridThickness”:0,”precision”:2,”thousandsSeparator”:”,”,”decimalSeparator”:”.”,”usePrefixes”:false,”mouseWheelZoomEnabled”:false,”cursorEnabled”:false,”exportEnabled”:false,”scrollbarEnabled”:false,”legendEnabled”:false,”periods”:”1W,1M,6M,YTD,1Y,ALL”,”defaultPeriod”:”1y”}’]

Key Share Information:

Key Balance Sheet Information (in Millions $CAD):

	CYQ1'17 Q3'17	CYQ2'17 Q4'17	CYQ3'17 Q1'18	CYQ4'17 Q2'18	CYQ1'18 Q3'18	CYQ2'18 Q4'18	CYQ3'18 Q1'19	CYQ4'18 Q2'19	CYQ1'19 Q3'19	CYQ2'19 Q4'19
Cash	$17.12	$19.31	$38.45	$1.74	$145.99	$0.96	$39.34	$23.28	$165.04	$173.09
Biological Assets	$0.22	$0.93	$1.50	$1.55	$1.19	$1.87	$2.33	$2.64	$4.20	$12.09
Inventory	$1.25	$1.25	$3.69	$5.91	$7.58	$9.24	$10.41	$16.24	$21.11	$36.78
Total Assets	$27.18	$31.40	$56.18	$57.77	$299.59	$301.65	$335.00	$383.31	$247.69	$510.45
Net Tangible Assets	$24.54	$28.78	$53.42	$55.01	$296.69	$298.15	$330.95	$378.88	$242.83	$504.84
Intangibles/Goodwill	$2.64	$2.62	$2.76	$2.76	$2.90	$3.50	$4.04	$4.43	$4.86	$5.62
Total Liabilities	$5.83	$4.10	$23.74	$26.34	$11.13	$9.83	$12.12	$17.44	$23.36	$47.39

Key Operating Items (Quarterly in Millions $CAD):

	CYQ1'17 Q3'17	CYQ2'17 Q4'17	CYQ3'17 Q1'18	CYQ4'17 Q2'18	CYQ1'18 Q3'18	CYQ2'18 Q4'18	CYQ3'18 Q1'19	CYQ4'18 Q2'19	CYQ1'19 Q3'19	CYQ2'19 Q4'19
Revenue	$0.91	$1.18	$4.10	$1.10	$1.18	$1.24	$4.93	$6.63	$16.18	$15.93
Change in Fair Value of Biologial Assets	-$0.59	-$1.41	-$5.66	-$2.83	-$1.05	-$2.48	-$7.34	-5.12	-8.35	-$20.06
Gross Margin	$0.94	$1.38	$6.45	$2.46	$0.75	$2.67	$6.40	7.24	11.60	$21.83
Marketing and Promotion	$0.66	$0.84	$2.99	$1.11	$1.36	$2.10	$8.34	11.71	4.84	$5.12
Total Operating Expenses	$1.94	$2.39	$7.93	$2.84	$5.49	$5.32	$24.37	22.03	18.49	$24.06
Operating Cash Flow (Quarterly)		-$5.79	-$1.93	-$1.17	-$5.64	-$4.60	-$10.77	-23.43	-15.08	-$5.93
Investing Cash Flow (Quarterly)		-$21.89	-$3.49	-$35.94	-$90.38	-$144.02	$10.26	-1.25	8.14	-$24.76
Financing Cash Flow (Quarterly)		$22.32	$24.55	$0.41	$240.27	$3.59	$38.89	8.61	56.42	$38.73

Listing Statement

All of the information on this dashboard was collected on a best efforts basis. This information should not be relied upon to make investment decisions. Always do your own diligence when purchasing a security and contact a licensed financial representative.